AZN
Price
$73.57
Change
-$1.00 (-1.34%)
Updated
Aug 8, 10:39 AM (EDT)
Capitalization
208.98B
90 days until earnings call
BAYRY
Price
$7.40
Change
+$0.15 (+2.07%)
Updated
Aug 7 closing price
Capitalization
57.55B
95 days until earnings call
Interact to see
Advertisement

AZN vs BAYRY

Header iconAZN vs BAYRY Comparison
Open Charts AZN vs BAYRYBanner chart's image
AstraZeneca
Price$73.57
Change-$1.00 (-1.34%)
Volume$7.67K
Capitalization208.98B
Bayer A.G
Price$7.40
Change+$0.15 (+2.07%)
Volume$2.55M
Capitalization57.55B
AZN vs BAYRY Comparison Chart in %
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. BAYRY commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a StrongBuy and BAYRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (AZN: $74.57 vs. BAYRY: $7.40)
Brand notoriety: AZN: Notable vs. BAYRY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 77% vs. BAYRY: 327%
Market capitalization -- AZN: $208.98B vs. BAYRY: $57.55B
AZN [@Pharmaceuticals: Major] is valued at $208.98B. BAYRY’s [@Pharmaceuticals: Major] market capitalization is $57.55B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whileBAYRY’s FA Score has 0 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • BAYRY’s FA Score: 0 green, 5 red.
According to our system of comparison, AZN is a better buy in the long-term than BAYRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 6 TA indicator(s) are bullish while BAYRY’s TA Score has 4 bullish TA indicator(s).

  • AZN’s TA Score: 6 bullish, 5 bearish.
  • BAYRY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AZN is a better buy in the short-term than BAYRY.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +2.02% price change this week, while BAYRY (@Pharmaceuticals: Major) price change was -4.39% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.66%. For the same industry, the average monthly price growth was +6.13%, and the average quarterly price growth was +13.71%.

Reported Earning Dates

AZN is expected to report earnings on Nov 06, 2025.

BAYRY is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.66% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZN($209B) has a higher market cap than BAYRY($57.5B). AZN has higher P/E ratio than BAYRY: AZN (35.30) vs BAYRY (17.04). BAYRY YTD gains are higher at: 52.362 vs. AZN (15.438). AZN has higher annual earnings (EBITDA): 13.4B vs. BAYRY (12.1B). BAYRY has more cash in the bank: 7.98B vs. AZN (5.86B). BAYRY has higher revenues than AZN: BAYRY (50.5B) vs AZN (45.8B).
AZNBAYRYAZN / BAYRY
Capitalization209B57.5B363%
EBITDA13.4B12.1B111%
Gain YTD15.43852.36229%
P/E Ratio35.3017.04207%
Revenue45.8B50.5B91%
Total Cash5.86B7.98B73%
Total Debt28.6BN/A-
FUNDAMENTALS RATINGS
AZN vs BAYRY: Fundamental Ratings
AZN
BAYRY
OUTLOOK RATING
1..100
1376
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
38100
SMR RATING
1..100
4694
PRICE GROWTH RATING
1..100
5149
P/E GROWTH RATING
1..100
8588
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZN's Valuation (27) in the Pharmaceuticals Major industry is somewhat better than the same rating for BAYRY (85) in the null industry. This means that AZN’s stock grew somewhat faster than BAYRY’s over the last 12 months.

AZN's Profit vs Risk Rating (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for BAYRY (100) in the null industry. This means that AZN’s stock grew somewhat faster than BAYRY’s over the last 12 months.

AZN's SMR Rating (46) in the Pharmaceuticals Major industry is somewhat better than the same rating for BAYRY (94) in the null industry. This means that AZN’s stock grew somewhat faster than BAYRY’s over the last 12 months.

BAYRY's Price Growth Rating (49) in the null industry is in the same range as AZN (51) in the Pharmaceuticals Major industry. This means that BAYRY’s stock grew similarly to AZN’s over the last 12 months.

AZN's P/E Growth Rating (85) in the Pharmaceuticals Major industry is in the same range as BAYRY (88) in the null industry. This means that AZN’s stock grew similarly to BAYRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNBAYRY
RSI
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
59%
Momentum
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
60%
MACD
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 10 days ago
54%
Bullish Trend 15 days ago
60%
Declines
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 9 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
48%
Aroon
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EWJ76.620.59
+0.78%
iShares MSCI Japan ETF
ITAN32.330.12
+0.37%
Sparkline Intangible Value ETF
IBDZ26.14-0.03
-0.11%
iShares iBonds Dec 2034 Term Corp ETF
SGDJ52.66-0.10
-0.19%
Sprott Junior Gold Miners ETF
FLIA20.48-0.08
-0.39%
Franklin International Aggregate Bd ETF

BAYRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYRY has been closely correlated with BAYZF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYRY jumps, then BAYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYRY
1D Price
Change %
BAYRY100%
+2.07%
BAYZF - BAYRY
88%
Closely correlated
+1.03%
OPHLY - BAYRY
23%
Poorly correlated
-0.45%
SNY - BAYRY
23%
Poorly correlated
+2.71%
AZN - BAYRY
21%
Poorly correlated
+0.12%
BIIB - BAYRY
20%
Poorly correlated
-3.87%
More